Evidence map›Paper›PMID 34264509›Full record

ReviewHepatology international2021

The overview of the deep learning integrated into the medical imaging of liver: a review.

Kailai Xiang, Baihui Jiang, Dong Shang

Abstract readReview
PubMed Publisher
In one paragraph

Review in Hepatology international, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Deep Learning Framework for Liver Segmentation fromSensors (Basel, Switzerland) · 2023
    Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Kailai XiangDepartment of General Surgery, First Affiliated Hospital of Dalian Medical University, Dalian, 116011, Liaoning, China.ORCID http://orcid.org/0000-0002-1243-2009
Baihui JiangDepartment of Ophthalmology, First Affiliated Hospital of Dalian Medical University, Dalian, 116011, Liaoning, China.
Dong ShangDepartment of General Surgery, First Affiliated Hospital of Dalian Medical University, Dalian, 116011, Liaoning, China. shangdong@dmu.edu.cn.

Funding

National Key Research and Development Program of China No. 2018YFE0195200National Natural Science Foundation of China No. 81873156The Leading Talent of Hundred, Thousand and Ten Thousand Project of Xingliao Gifted Person Program of Liaoning Province XLYC1905013
6 · The paper itself

Abstract

Deep learning (DL) is a recently developed artificial intelligent method that can be integrated into numerous fields. For the imaging diagnosis of liver disease, several remarkable outcomes have been achieved with the application of DL currently. This advanced algorithm takes part in various sections of imaging processing such as liver segmentation, lesion delineation, disease classification, process optimization, etc. The DL optimized imaging diagnosis shows a broad prospect instead of the pathological biopsy for the advantages of convenience, safety, and inexpensiveness. In this paper, we reviewed the published representative DL-related hepatic imaging works, described the general situation of this new-rising technology in medical liver imaging and explored the future direction of DL development.

Indexed as

Deep LearningArtificial IntelligenceDiagnostic ImagingHumansImage Processing, Computer-AssistedLiverArtificial intelligenceComputed tomographyConvolutional neural networkDeep learningImage segmentationImaging diagnosisLesion classificationLiver diseaseMagnetic resonance imagingUltrasonography

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.